Search details
1.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37334852
2.
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; : 10781552231189199, 2023 Aug 21.
Article
in English
| MEDLINE | ID: mdl-37603585
3.
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
J Oncol Pharm Pract
; 28(4): 892-897, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35191732
4.
Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; 27(3): 771-775, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-32819196
5.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Article
in English
| MEDLINE | ID: mdl-30256954
6.
Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease.
Am J Hematol
; 97(7): E273-E276, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35413140
7.
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.
Leuk Lymphoma
; 65(2): 250-256, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38264905
8.
OUTER RETINOPATHY AND MICROANGIOPATHY IN ACUTE MYELOGENOUS LEUKEMIA.
Retin Cases Brief Rep
; 17(6): 683-689, 2023 Nov 01.
Article
in English
| MEDLINE | ID: mdl-37903306
9.
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Transplant Cell Ther
; 29(2): 113-118, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36336258
10.
Dimerization of MLL fusion proteins immortalizes hematopoietic cells.
Cancer Cell
; 4(3): 197-207, 2003 Sep.
Article
in English
| MEDLINE | ID: mdl-14522254
11.
Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis.
Transplant Cell Ther
; 28(9): 590-596, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35772699
12.
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia.
Leuk Lymphoma
; 63(7): 1645-1650, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35259056
13.
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
Blood Adv
; 6(13): 3997-4005, 2022 07 12.
Article
in English
| MEDLINE | ID: mdl-35507945
14.
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.
Leuk Lymphoma
; 63(8): 1925-1933, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35188052
15.
Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 27(11): 934.e1-934.e6, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34339867
16.
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay.
Transplant Cell Ther
; 27(5): 431.e1-431.e8, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33965188
17.
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation.
Leuk Lymphoma
; 61(9): 2200-2207, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32482107
18.
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
Bone Marrow Transplant
; 54(2): 212-217, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29795429
19.
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Mol Cell Biol
; 24(2): 617-28, 2004 Jan.
Article
in English
| MEDLINE | ID: mdl-14701735
20.
Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Cancer Res
; 65(24): 11367-74, 2005 Dec 15.
Article
in English
| MEDLINE | ID: mdl-16357144